Clinical Trials Browser

Phase 1/2 × Unknown × Infusions, Intravenous × Clear all

NCT05448599 2023-03-15

A Clinical Study of 6MW3211 Monotherapy or Combination Therapy for AML or MDS

Phase 1/2 Unknown

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05524194 2022-09-01

6MW3511 in Patients With Advanced Solid Tumor

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumors

NCT05048160 2022-05-09

A Clinical Study of 6MW3211 Injection in the Treatment of Advanced Malignant Neoplasm

Phase 1/2 Unknown

Advanced Malignant Neoplasm